Sale!

TSEN54 Gene Pontocerebellar Hypoplasia Type 2A Genetic Test

Original price was: $700.Current price is: $500.

-29%

The TSEN54 Gene Pontocerebellar Hypoplasia Type 2A NGS Genetic DNA Test is a specialized diagnostic tool that identifies mutations in the TSEN54 gene associated with pontocerebellar hypoplasia type 2A. This neurological disorder affects brain development in infants and children, leading to severe developmental delays, movement disorders, and respiratory complications. Using advanced Next-Generation Sequencing technology, this test provides comprehensive analysis of the TSEN54 gene to confirm diagnosis, guide treatment decisions, and offer crucial information for family planning. The test costs $500 USD and is particularly valuable for families with a history of neurological disorders or when infants show unexplained developmental regression.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

TSEN54 Gene Pontocerebellar Hypoplasia Type 2A NGS Genetic DNA Test

Understanding Pontocerebellar Hypoplasia Type 2A

Pontocerebellar hypoplasia type 2A (PCH2A) is a rare, inherited neurological disorder that affects brain development, specifically targeting the pons and cerebellum regions. These critical brain structures are responsible for coordinating movement, balance, and essential autonomic functions. The condition typically manifests in infancy and leads to progressive neurological deterioration, making early and accurate diagnosis crucial for proper management and family planning.

What This Test Measures and Detects

Our advanced NGS Genetic DNA Test specifically analyzes the TSEN54 gene, which encodes a crucial component of the transfer RNA splicing endonuclease complex. This test identifies:

  • Pathogenic mutations in the TSEN54 gene
  • Single nucleotide variants and small insertions/deletions
  • Compound heterozygous mutations
  • Autosomal recessive inheritance patterns
  • Specific genetic markers associated with PCH2A severity

Who Should Consider This Test

This genetic test is recommended for individuals showing symptoms or with family history indicating pontocerebellar hypoplasia:

  • Infants with unexplained developmental regression
  • Children exhibiting progressive microcephaly
  • Patients with chorea or dystonia movements
  • Individuals with feeding difficulties and respiratory problems
  • Families with history of similar neurological conditions
  • Couples planning pregnancy with known family history

Key Clinical Indications

Specific symptoms that warrant consideration of TSEN54 testing include:

  • Progressive microcephaly developing after birth
  • Severe developmental delay with loss of milestones
  • Extrapyramidal movement disorders
  • Visual impairment and optic atrophy
  • Respiratory complications requiring support
  • Feeding difficulties and swallowing problems

Benefits of TSEN54 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out PCH2A with high precision
  • Family Planning Guidance: Enables informed reproductive decisions
  • Treatment Planning: Guides appropriate therapeutic interventions
  • Prognostic Information: Helps understand disease progression expectations
  • Genetic Counseling: Provides basis for comprehensive family counseling
  • Research Contribution: Advances understanding of rare neurological disorders

Understanding Your Test Results

Our genetic specialists provide detailed interpretation of your results:

Positive Result

A positive result indicates the presence of pathogenic mutations in the TSEN54 gene, confirming the diagnosis of pontocerebellar hypoplasia type 2A. This information enables:

  • Development of targeted care plans
  • Implementation of appropriate supportive therapies
  • Family genetic counseling sessions
  • Connection with specialized neurological care teams

Negative Result

A negative result suggests that TSEN54 mutations are not the cause of the observed symptoms, guiding physicians toward alternative diagnostic pathways and other potential genetic causes.

Variant of Uncertain Significance

In some cases, genetic variations of unknown clinical significance may be identified. Our team provides ongoing monitoring and reclassification as new research emerges.

Test Details and Pricing

Test Component Details
Test Name TSEN54 Gene Pontocerebellar Hypoplasia Type 2A NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

To ensure the most accurate results and comprehensive care, we require:

  • Complete clinical history of the patient
  • Genetic counseling session prior to testing
  • Detailed pedigree chart of affected family members
  • Neurological evaluation documentation

Nationwide Accessibility

We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network ensures that comprehensive genetic testing is accessible to families nationwide.

Take the Next Step Toward Answers

If you or your loved one is experiencing symptoms suggestive of pontocerebellar hypoplasia or has a family history of neurological disorders, don’t wait to get answers. Our specialized genetic testing provides the clarity needed for proper diagnosis and management.

Call us today at +1(267) 388-9828 to schedule your genetic counseling session and TSEN54 testing. Our compassionate team of genetic specialists is ready to guide you through the testing process and help you understand your results.

Early genetic diagnosis can make a significant difference in managing neurological conditions and planning for the future. Take control of your health journey with our comprehensive TSEN54 Gene Pontocerebellar Hypoplasia Type 2A NGS Genetic DNA Test.